NCT05425992Recruiting
Improving Communication and Building a Stronger Medical Home Among Spanish-speaking Families
Improving Communication With and Building a Stronger Medical Home Among Spanish-speaking Families in the Center for Cancer and Blood Disorders
Source: ClinicalTrials.gov · Last updated 5 Feb 2026
Brief summary (registry, in English)
This study will seek to improve communication with Spanish speaking families and patients with Cancer and Blood Disorders.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 20 (estimated)
- First submitted
- 15 Jun 2022
- Start date
- 17 Mar 2022
- Primary completion date
- 31 Dec 2027
- Lead sponsor
- University of Colorado, Denver
- Diseases
- Childhood cancers
- NCT number
- NCT05425992
What you commit to
- Study type: Observational
- Planned participants: 20
- From 17 Mar 2022 to the primary completion date, 31 Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who received care solely outside of the CCBD
Other
- Patients without oncologic diagnosis
- Patients with parents whose language preference is English
Who the study is looking for
- 0 to 22 years of age
- Diagnosis of leukemia or non-Hodgkin lymphoma
- Spanish as preferred language for patient, parent or guardian
- Received or receiving care at the Center for Cancer and Blood Disorders (CCBD)
Age in the registry: - to 22 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Children's Hospital Colorado Coordinator of this site? Confirm its status | Aurora | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.